Share

April 13, 2021; 96 (15 Supplement) Saturday, April 17

A Retrospective Cohort Study of Medical Cannabis Treatment in Patients with Glioblastoma Multiforme (4639)

Vincent Bargnes, Laszlo Mechtler, Christopher Ralyea, Paul Hart, Alex Benyovszky
First published April 13, 2021,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 96 no. 15 Supplement 4639
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 13, 2021.
Copyright & Usage: 
© 2021

Author Disclosures

    1. Vincent Bargnes1,
    2. Laszlo Mechtler1,
    3. Christopher Ralyea1,
    4. Paul Hart1 and
    5. Alex Benyovszky1
  1. Vincent Bargnes1,
  2. Laszlo Mechtler1,
  3. Christopher Ralyea1,
  4. Paul Hart1 and
  5. Alex Benyovszky1
  1. 1Cannabis Clinic and Research Center, Dent Neurologic Institute

Article usage

Article usage: April 2021 to October 2023

AbstractFullPdfSource
Apr 20214200Highwire
May 20212700Highwire
Jun 2021700Highwire
Jul 20211500Highwire
Aug 2021700Highwire
Sep 20211300Highwire
Oct 20211500Highwire
Nov 20219700Highwire
Dec 20212200Highwire
Jan 20221600Highwire
Feb 20221300Highwire
Mar 2022900Highwire
Apr 2022800Highwire
May 20228400Highwire
Jun 2022500Highwire
Jul 2022800Highwire
Aug 2022300Highwire
Sep 2022500Highwire
Oct 20222200Highwire
Nov 2022800Highwire
Dec 2022800Highwire
Jan 20231500Highwire
Feb 2023700Highwire
Mar 20232200Highwire
Apr 2023500Highwire
May 2023100Highwire
Jun 2023600Highwire
Jul 2023100Highwire
Aug 2023400Highwire
Sep 2023400Highwire
Oct 2023400Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me